Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.Baituxiao Botanical Formula: Product, Label and Evidence Profile
Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…
Read more
CHOP-Style Chemotherapy for Canine Lymphoma: Protocol Discussion Profile
CHOP is a family of veterinary lymphoma protocols built around cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine and prednisone. Exact sequence, dose and duration vary by oncology service and patient.
Read more
Carboplatin in Veterinary Oncology: Infusion, Monitoring, and Safety Profile
Carboplatin is a platinum-based cytotoxic chemotherapy drug used by veterinary oncologists for selected canine and feline cancers. Its use in companion animals is veterinarian-directed and generally extra-label; it…
Read moreDoxorubicin in Veterinary Oncology: Infusion and Cumulative-Risk Profile
Doxorubicin is an anthracycline cytotoxic chemotherapy drug used by veterinary oncologists for lymphoma and several sarcomas and carcinomas. Companion-animal use is veterinarian-directed and generally extra-label, with drug-specific infusion…
Read more
Lomustine (CCNU) in Veterinary Oncology: Delayed-Toxicity Safety Profile
Lomustine, also called CCNU, is an oral nitrosourea chemotherapy drug used by veterinary oncologists for selected cancers. Use in dogs and cats is generally extra-label and requires a…
Read moreVincristine in Veterinary Oncology: IV Safety and Monitoring
Vincristine is a vinca alkaloid used within selected veterinary chemotherapy protocols and requires precise intravenous administration and protocol-specific monitoring.
Read more
Cyclophosphamide in Cancer Protocols: Bladder and Marrow Safety
Cyclophosphamide is an alkylating chemotherapy used in selected veterinary protocols, with blood-count, urinary, gastrointestinal, and household-safety considerations.
Read moreVinblastine in Veterinary Oncology: Protocol and Extravasation Awareness
Vinblastine is an intravenous vinca alkaloid used in selected veterinary protocols and demands venous, blood-count, gastrointestinal, and interaction monitoring.
Read moreChlorambucil: Oral Chemotherapy Is Still Hazardous Medicine
Chlorambucil is an oral alkylating chemotherapy used in selected slow-growing blood cancers and other protocols, with cumulative marrow and handling considerations.
Read moreMelphalan in Veterinary Oncology: Cumulative Marrow-Risk Discussion
Melphalan is an alkylating antineoplastic medicine used in selected veterinary cancers and requires individualized blood-count, gastrointestinal, and handling plans.
Read moreMitoxantrone in Veterinary Oncology: Infusion and Blood-Count Profile
Mitoxantrone is an intravenous antineoplastic medicine used in selected canine and feline protocols, with infusion, marrow, and gastrointestinal monitoring.
Read moreGemcitabine in Veterinary Oncology: Limited and Protocol-Specific Evidence
Gemcitabine is an intravenous antimetabolite considered in selected veterinary protocols, where evidence and toxicity must be reviewed for the exact diagnosis.
Read more